Literature DB >> 32542561

The COVID-19 infection in dialysis: are home-based renal replacement therapies a way to improve patient management?

Mario Cozzolino1, Giorgina Barbara Piccoli2,3, Talat Alp Ikizler4, Claudio Ronco5,6.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32542561      PMCID: PMC7294214          DOI: 10.1007/s40620-020-00784-3

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


× No keyword cloud information.
The novel coronavirus initially called SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus 2), and subsequently renamed COVID-19 (Corona Virus Disease 2019) was identified in Wuhan, China in December 2019. Since then, it has spread worldwide, and in some countries it has had an exponential, and initially unexpected, impact. It was declared a pandemic in March 2020 by the World Health Organization. The elderly and patients with comorbid conditions such as hypertension, heart disease, diabetes, lung disease, and immunologic disorders were soon identified as being at risk of contracting a severe infection [1]. Various measures of containment were undertaken to prevent the spread of COVID-19, initially without in-depth knowledge of the clinical and epidemiological characteristics of the virus. Patients with advanced chronic kidney disease (CKD), in particular, those on dialysis are a vulnerable population and a challenge in the prevention and control of the disease. As the virus is transmitted through droplets and contact, treatments that need to be performed in limited, dedicated spaces require special care; hemodialysis units can be taken as the prototype of such settings [2, 3]. In northern Italy, we were the first in Europe to have to cope with the need to continue to manage our chronic dialysis patients while continuously adapting to the rapidly evolving emergency situation. Hundreds of patients were diagnosed as affected by COVID-19 in Italy’s northern regions, where the pandemic first hit, and the figures are probably underestimated, due to the low availability of tests, especially during the first phase of the epidemic. For example, in two of the of the largest renal units in Milan, near the epicenter of the Italian epidemic, where 330 hemodialysis (HD) patients and 50 peritoneal dialysis (PD) patients are followed, we tried to reduce exposure and the risk of contagion by decreasing the number of patients per shift in order to provide safe distance between patients during hemodialysis. To do so, we rapidly equipped additional treatment space with ten hemodialysis stations and added dialysis shifts. However, this led to staff shortages, which were already critical as members of the health care team had been infected. Although new stations were added, treatment time had to be shortened wherever clinically possible. In our Unit, 20 HD and 1 PD patient were diagnosed as having COVID-19 and 5 died. Peritoneal dialysis patients were relatively spared and the advantages of this technique rapidly became evident, as did the importance of monitoring [4, 5]. Now that the epidemic is reaching a plateau, it is time to reflect on the lessons that could, and probably should transform our models of delivering dialysis. Outpatient, thrice-weekly hemodialysis is the standard of care in most countries, including Italy; dialysis delivery is often, probably too often, performed in a standardized way, and the population of mainly elderly and high-comorbidity patients often passively receives this intrusive, albeit life-sustaining treatment. Under the pressure of need, we were obliged to tailor hemodialysis sessions to mediate between logistics and clinical priorities. This mediation further highlights how an incremental dialysis strategy, based on number of sessions as well as their duration, can be safe and patient-friendly for many subjects with some residual kidney function [6]. During an epidemic incremental approaches play an important role in limiting exposure; implementing the lessons in times of less pressure could lead to a personalized approach that limits morbidity, respects residual kidney function and minimizes iatrogenic impact. However, tailoring dialysis can be time consuming, and requires frequent monitoring. If on the one hand this could be seen as too demanding for overcrowded dialysis wards, the spare time for the patient and cost for the society could theoretically be reinvested in dedicated physician’s time (Table 1).
Table 1

Logistic considerations regarding home dialysis treatments, and potential interferences in times of crisis

AdvantagesLimitsPotential interference in case of epidemic
Home-based treatmentMakes it possible to limit exposure to the hospital setting

Isolation.

Acute intradialytic problems can be challenging

Less exposure to the hospital milieu; links should be reinforced using telemedicine
Remote counselingA good way to avoid isolation; should integrate direct follow-upFragile and elderly patients may not be able to clearly explain their problemsMay need to be increased during epidemics to avoid isolation. An “urgent pathway” has to be ensured
Flexibility—empowermentPatient empowerment is associated with better survival and better quality of lifePatient-designed dialysis may differ from prescriptions. This can be dangerousRemote counseling should be reinforced, to avoid the introduction of subtle but important changes to prescriptions
Biochemical controls at homePractical, reduces the need for going to a laboratory or hospitalStandard pre- and post- dialysis controls may be difficult to organizeCare needs to be taken so that the frequency of controls is not reduced (except in acute epidemic phases)
Family involvementCan provide important psychological supportThe burden may be heavy and create tensionPsychological aid could be needed, and would need to be reinforced in moments of crisis
Residual kidney functionMay be better preserved in tailored dialysis programsMonitoring may be difficult to carry out, and slow loss of kidney function could go unnoticedParticular attention needs to be paid if only remote monitoring is employed
Assisted home dialysisAllows limiting exposure to the hospital setting and eliminates travel timeMay fail to guarantee privacy. The advantage of empowerment is usually lostAids are exposed to contagion and become potential carriers
Reduction of travel time—lower carbon footprintThe ecologic advantages are debated, but are likely to be relevant especially if patients live far from the dialysis unitsIn some settings, the costs for the patients may be high. Waste management needs to be organized in advanceLimiting need to travel is an advantage in case of lockdown
OtherThe clinical results of home dialysis are usually at least competitive with hospital-based therapyHome dialysis may be time consuming for the health care team, in particular if a personalized schedule is chosenDelivering supplies may prove difficult to organize during lockdown; technical aid may be delayed. Home dialysis has to be a clear priority for technical aid and delivery of disposables
Logistic considerations regarding home dialysis treatments, and potential interferences in times of crisis Isolation. Acute intradialytic problems can be challenging The issue of personalized incremental dialysis is intrinsically linked with home dialysis, in both HD and PD. The present epidemic has highlighted some of the limits of standard, thrice-weekly outpatient hemodialysis: it lacks flexibility, and large units are often preferred, given their economies of scale [7, 8]. Home-based renal replacement therapies have many advantages in this regard. First of all, they offer the opportunity to manage patients remotely, thus reducing contagion during an epidemic. The French health council, as well as some patients’ associations, recently underlined the importance of developing home dialysis choices to respond to the COVID crisis. Home dialysis involves making patients responsible for their own care and patient empowerment facilitates personalization of treatment. In this regard, the Advancing American Kidney Health Initiative (AAKHI) underlines that home dialysis should be promoted as an opportunity for patients to be engaged in their own treatment. Flexibility applies not only to dialysis itself, but also to diet and, more widely, to lifestyle. The list of advantages of home dialysis is long and encompasses better preservation of residual kidney function, at least in PD and incremental hemodialysis, saving time, limiting travel from center to home and vice versa, lower costs (this issue is somewhat controversial), and possibly a smaller carbon footprint [9]. Home dialysis is however underdeveloped, for clinical, cultural and economic reasons [8]. In-hospital dialysis is often seen as simpler for the nursing staff and less demanding for the patient; since it is standardized it is also thought to reduce the physician’s involvement. Are these real advantages? To face this crisis, many dialysis physicians had to invent solutions overnight, and, overall, succeeded in doing so. The same flexibility and innovation should be applied to an in-depth revision of our practice, promoting home-based therapies: tailormade schedules, assisted home dialysis, strict telemonitoring, and home visits can be combined to make home dialysis possible and often preferable for fragile patients. This may not be simple, but it is certainly feasible (Table 1). In summary, as we endure this unprecedented catastrophe, we should try to learn from it to improve the care of our vulnerable population. Considering the efficacy of lockdown in preventing the spread of the infection, home dialysis represents an ideal approach in the case of epidemics. It is a good opportunity for us to reconsider its value, and develop new approaches to make home and personalized treatments more widely available, as a strategic reinvestment not only in these times of crisis, but, even more importantly, in calmer times to come, hopefully soon.
  9 in total

1.  Home haemodialysis: how it began, where it went wrong, and what it may yet be.

Authors:  John W M Agar; Katherine A Barraclough; Giorgina B Piccoli
Journal:  J Nephrol       Date:  2019-03-19       Impact factor: 3.902

Review 2.  Remote patient management of peritoneal dialysis during COVID-19 pandemic.

Authors:  Claudio Ronco; Sabrina Milan Manani; Anna Giuliani; Ilaria Tantillo; Thiago Reis; Edwina A Brown
Journal:  Perit Dial Int       Date:  2020-06-29       Impact factor: 1.756

3.  Lessons from the Experience in Wuhan to Reduce Risk of COVID-19 Infection in Patients Undergoing Long-Term Hemodialysis.

Authors:  Junhua Li; Gang Xu
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-02       Impact factor: 8.237

Review 4.  Peritoneal Dialysis in the time of COVID-19.

Authors:  Martin Wilkie; Simon Davies
Journal:  Perit Dial Int       Date:  2020-04-21       Impact factor: 1.756

5.  Incremental dialysis in ESRD: systematic review and meta-analysis.

Authors:  Carlo Garofalo; Silvio Borrelli; Toni De Stefano; Michele Provenzano; Michele Andreucci; Gianfranca Cabiddu; Vincenzo La Milia; Valerio Vizzardi; Massimo Sandrini; Giovanni Cancarini; Adamasco Cupisti; Vincenzo Bellizzi; Roberto Russo; Paolo Chiodini; Roberto Minutolo; Giuseppe Conte; Luca De Nicola
Journal:  J Nephrol       Date:  2019-01-02       Impact factor: 3.902

6.  Green nephrology and eco-dialysis: a position statement by the Italian Society of Nephrology.

Authors:  Giorgina Barbara Piccoli; Adamasco Cupisti; Filippo Aucella; Giuseppe Regolisti; Carlo Lomonte; Martina Ferraresi; D'Alessandro Claudia; Carlo Ferraresi; Roberto Russo; Vincenzo La Milia; Bianca Covella; Luigi Rossi; Antoine Chatrenet; Gianfranca Cabiddu; Giuliano Brunori
Journal:  J Nephrol       Date:  2020-04-15       Impact factor: 3.902

7.  Kidney disease is associated with in-hospital death of patients with COVID-19.

Authors:  Yichun Cheng; Ran Luo; Kun Wang; Meng Zhang; Zhixiang Wang; Lei Dong; Junhua Li; Ying Yao; Shuwang Ge; Gang Xu
Journal:  Kidney Int       Date:  2020-03-20       Impact factor: 10.612

8.  Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy.

Authors:  Giuseppe Rombolà; Marco Heidempergher; Luciano Pedrini; Marco Farina; Filippo Aucella; Piergiorgio Messa; Giuliano Brunori
Journal:  J Nephrol       Date:  2020-04       Impact factor: 3.902

9.  Hospitals as health factories and the coronavirus epidemic.

Authors:  Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2020-04       Impact factor: 4.393

  9 in total
  3 in total

Review 1.  COVID-19 pandemic era: is it time to promote home dialysis and peritoneal dialysis?

Authors:  Mario Cozzolino; Ferruccio Conte; Fulvia Zappulo; Paola Ciceri; Andrea Galassi; Irene Capelli; Giacomo Magnoni; Gaetano La Manna
Journal:  Clin Kidney J       Date:  2021-02-02

Review 2.  The Impact of Old and Novel Cardiovascular Risk Factors.

Authors:  Manuel Alfredo Podestà; Federica Valli; Andrea Galassi; Matthias A Cassia; Paola Ciceri; Lucia Barbieri; Stefano Carugo; Mario Cozzolino
Journal:  Blood Purif       Date:  2021-03-22       Impact factor: 2.614

3.  Why and how should we promote home dialysis for patients with end-stage kidney disease during and after the coronavirus 2019 disease pandemic? A French perspective.

Authors:  Guy Rostoker; Belkacem Issad; Hafedh Fessi; Ziad A Massy
Journal:  J Nephrol       Date:  2021-06-01       Impact factor: 3.902

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.